Toxoplasma gondii and other risk factors for schizophrenia: an update
- PMID: 22446566
- PMCID: PMC3329973
- DOI: 10.1093/schbul/sbs043
Toxoplasma gondii and other risk factors for schizophrenia: an update
Abstract
The failure to find genes of major effect in schizophrenia has refocused attention on nongenetic, including infectious factors. In a previous study, antibodies to Toxoplasma gondii were found to be elevated in 23 studies of schizophrenia (OR 2.73; 95% CI 2.10-3.60). The current study replicates this finding with 15 additional studies (OR 2.71; 95% CI 1.93-3.80) and compares this with other identified schizophrenia risk factors. The highest risk factors are having an affected mother (relative risks [RR] 9.31; 95% CI 7.24-11.96), father (RR 7.20; 95% CI 5.10-10.16), or sibling (RR 6.99; 95% CI 5.38-9.08) or being the offspring of immigrants from selected countries (RR 4.5; 95% CI 1.5-13.1). Intermediate risk factors, in addition to infection with T. gondii, include being an immigrant from and to selected countries (RR 2.7; 95% CI 2.3-3.2), being born in (RR 2.24; 95% CI 1.92-2.61) or raised in (RR 2.75; 95% CI 2.31-3.28) an urban area, cannabis use (OR 2.10-2.93; 95% CI 1.08-6.13), having minor physical anomalies (OR 2.23; 95% CI 1.42-3.58), or having a father 55 or older (OR 2.21-5.92; 95% CI 1.46-17.02). Low-risk factors include a history of traumatic brain injury (OR 1.65; 95% CI 1.17-2.32), sex abuse in childhood (OR 1.46; 95% CI 0.84-2.52), obstetrical complications (OR 1.29-1.38; 95% CI 1.00-1.84), having a father 45 or older (OR 1.21-1.66; 95% CI 1.09-2.01), specific genetic polymorphisms (OR 1.09-1.24; 95% CI 1.06-1.45), birth seasonality (OR 1.07-1.95; 95% CI 1.05-2.91), maternal exposure to influenza (RR 1.05; 95% CI 0.98-1.12), or prenatal stress (RR 0.98-1.00; 95% CI 0.85-1.16).
Figures
Similar articles
-
Toxoplasma gondii and schizophrenia.Emerg Infect Dis. 2003 Nov;9(11):1375-80. doi: 10.3201/eid0911.030143. Emerg Infect Dis. 2003. PMID: 14725265 Free PMC article. Review.
-
Toxoplasma and schizophrenia.Parasite Immunol. 2009 Nov;31(11):706-15. doi: 10.1111/j.1365-3024.2009.01131.x. Parasite Immunol. 2009. PMID: 19825110 Review.
-
Relationship between Toxoplasma gondii seropositivity and schizophrenia in the Lebanese population: potential implication of genetic polymorphism of MMP-9.BMC Psychiatry. 2020 May 27;20(1):264. doi: 10.1186/s12888-020-02683-0. BMC Psychiatry. 2020. PMID: 32460746 Free PMC article.
-
Toxoplasma gondii antibody titers and history of suicide attempts in patients with schizophrenia.Schizophr Res. 2011 Dec;133(1-3):150-5. doi: 10.1016/j.schres.2011.08.006. Epub 2011 Sep 3. Schizophr Res. 2011. PMID: 21890329
-
[Toxoplasma gondii: a potential role in the genesis of psychiatric disorders].Encephale. 2013 Feb;39(1):38-43. doi: 10.1016/j.encep.2012.06.014. Epub 2012 Aug 21. Encephale. 2013. PMID: 23095600 Review. French.
Cited by
-
Microbes and Mental Illness: Past, Present, and Future.Healthcare (Basel). 2023 Dec 29;12(1):83. doi: 10.3390/healthcare12010083. Healthcare (Basel). 2023. PMID: 38200989 Free PMC article. Review.
-
Establishing associated risk factors, including fungal and parasitic infections among Malaysians living with schizophrenia.Sci Rep. 2024 Jan 3;14(1):385. doi: 10.1038/s41598-023-50299-7. Sci Rep. 2024. PMID: 38172146 Free PMC article.
-
Role of Maternal Immune Factors in Neuroimmunology of Brain Development.Mol Neurobiol. 2023 Dec 7. doi: 10.1007/s12035-023-03749-2. Online ahead of print. Mol Neurobiol. 2023. PMID: 38057641 Review.
-
Emerging and Re-Emerging Parasitic Infections of the Central Nervous System (CNS) in Europe.Infect Dis Rep. 2023 Oct 25;15(6):679-699. doi: 10.3390/idr15060062. Infect Dis Rep. 2023. PMID: 37987400 Free PMC article. Review.
-
Relationship between Toxoplasma gondii infection and psychiatric disorders in Iran: A systematic review with meta-analysis.PLoS One. 2023 Aug 8;18(8):e0284954. doi: 10.1371/journal.pone.0284954. eCollection 2023. PLoS One. 2023. PMID: 37552680 Free PMC article.
References
-
- Matheson SL, Shepherd AM, Laurens KR, Carr JV. A systematic meta-review grading the evidence for non-genetic risk factors and putative antecedents of schizophrenia. Schizophr Res. 2011;133:133–142. - PubMed
-
- Fisher LD, Van Bell G. Biostatistics: A Methodology for the Health Sciences. 2nd ed. Hoboken, NJ: John Wiley and Sons; 2004. p. 165.
-
- Tanyüksel M, Uzun O, Araz E, Koru O, Babür C. Possible role of toxoplasmosis in patients with first-episode schizophrenia. Turk J Med Sci. 2010;40:399–404.
